ScoreWhy is Indoco Remedies Ltd ?
1
Weak Long Term Fundamental Strength with a -36.71% CAGR growth in Operating Profits over the last 5 years
- Low ability to service debt as the company has a high Debt to EBITDA ratio of 4.35 times
- The company has been able to generate a Return on Equity (avg) of 7.83% signifying low profitability per unit of shareholders funds
2
The company has declared Negative results for the last 13 consecutive quarters
- INTEREST(9M) At Rs 76.32 cr has Grown at 47.00%
- ROCE(HY) Lowest at -2.14%
- DEBT-EQUITY RATIO(HY) Highest at 1.02 times
3
Stock is technically in a Mildly Bearish range
- The technical trend has deteriorated from Sideways on 15-Jun-26 and has generated -2.33% returns since then
- The stocks MACD and KST technical factors are also Bearish
4
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -18.54% returns in the last 1 year, the stock has also underperformed BSE500 in each of the last 3 annual periods
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Indoco Remedies for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
Indoco Remedies
-18.54%
-0.39
47.91%
Sensex
-4.95%
-0.37
13.26%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
8.25%
EBIT Growth (5y)
-36.71%
EBIT to Interest (avg)
6.02
Debt to EBITDA (avg)
4.43
Net Debt to Equity (avg)
1.13
Sales to Capital Employed (avg)
1.08
Tax Ratio
7.33%
Dividend Payout Ratio
-2.50%
Pledged Shares
0
Institutional Holding
19.09%
ROCE (avg)
10.05%
ROE (avg)
7.83%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
34
Price to Book Value
2.27
EV to EBIT
207.48
EV to EBITDA
22.46
EV to Capital Employed
1.60
EV to Sales
1.73
PEG Ratio
NA
Dividend Yield
0.09%
ROCE (Latest)
0.77%
ROE (Latest)
-9.82%
Loading Valuation Snapshot...
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bearish
Moving Averages
Mildly Bearish (Daily)
KST
Bullish
Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend0What is working for the Company
NO KEY POSITIVE TRIGGERS
-9What is not working for the Company
INTEREST(9M)
At Rs 76.32 cr has Grown at 47.00%
ROCE(HY)
Lowest at -2.14%
DEBT-EQUITY RATIO(HY)
Highest at 1.02 times
DEBTORS TURNOVER RATIO(HY)
Lowest at 3.73 times
Loading Valuation Snapshot...
Here's what is not working for Indoco Remedies
Interest - Nine Monthly
At Rs 76.32 cr has Grown at 47.00%
over preceding nine months periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (Rs cr)
Debt-Equity Ratio - Half Yearly
Highest at 1.02 times and Grown
each half year in the last five half yearly periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Debtors Turnover Ratio- Half Yearly
Lowest at 3.73 times
in the last five half yearly periodsMOJO Watch
Company's pace of settling its Debtors has slowed
Debtors Turnover Ratio
